Bcx9930, An Oral Factor D Inhibitor, For The Potential Treatment Of Alternative Pathway Mediated Diseases: Interim Results Of A Phase 1 Study In Healthy SubjectsMatthew Davidson,Amanda Mathis,Stuart Mair,Diane Gesty-Palmer,Melanie Cornpropst,William P. Sheridan,Xilin Chen,David Reynolds,Cynthia Parker,Yarlagadda S. BabuBLOOD(2020)引用 4|浏览26暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要